Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
Massachusetts General Hospital
Massachusetts General Hospital
West China Hospital
Precision Biotech Taiwan Corp.
Petrov, Andrey
Amgen
Boehringer Ingelheim
Dana-Farber Cancer Institute
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
West China Hospital
University of California, Davis
OHSU Knight Cancer Institute
University of Washington
Vanderbilt-Ingram Cancer Center
Saint John's Cancer Institute
Shanghai JMT-Bio Inc.
H. Lee Moffitt Cancer Center and Research Institute
Johannes Gutenberg University Mainz
Vanderbilt-Ingram Cancer Center
Yonsei University
Boehringer Ingelheim
Boehringer Ingelheim
Ludwig-Maximilians - University of Munich
Groupe Oncologie Radiotherapie Tete et Cou
Memorial Sloan Kettering Cancer Center
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Memorial Sloan Kettering Cancer Center
Boehringer Ingelheim